Both in Pharmaceuticals
SELLAS Life Sciences Group vs Xeris Biopharma Holdings
Over the past year SLS returned +450.6% and XERS returned +5.7%; their daily moves had a correlation of 0.16.
SLS +450.6% XERS +5.7%Growth of $1, one year, split-adjusted
| Metric | SLS | XERS |
|---|---|---|
| Price | $9.14 | $10.46 |
| Market cap | $1.85B | $1.91B |
| Today | +3.04% | +1.06% |
| 1 month | −19.4% | +3.9% |
| 6 months | +77.5% | +64.2% |
| Year to date | +142.4% | +33.2% |
| 1 year | +410.6% | +5.7% |
| Revenue growth (YoY) | — | +28.7% |
| Gross margin | — | 86.4% |
| Net margin | — | −33.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.7× |
| Net cash | $138.3M | -$130.8M |
| Dividend yield | — | — |
| Volatility (60d) | 97.0% | 51.6% |
| Short % of float | 27.0% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).